The deal calls for the companies will collaborate on improving the screening for diabetic retinopathy and diabetic macular edema, both among the leading causes of blindness worldwide.
The program combines Nikon’s leadership in optical engineering and precision manufacturing and Verily’s machine-learning technology to help healthcare providers diagnose the conditions, according to a press release.
In February 2015, Nikon paid $400 million to acquire Optos, marking the Japanese camera giant’s 1st foray into the medical sector. Optos is the market leader in retinal imaging and its ultra-widefield technology produces images that cover more than 80% of the retina, which is greater than any other device.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!